{"organizations": [], "uuid": "99e0fb3363fa43820c576b971719692fffd6862c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-us-fda-observes-alembic-pharma-fai/brief-u-s-fda-observes-alembic-pharma-failed-to-review-any-unexplained-discrepancy-on-inspection-of-cos-panelav-plant-cnbc-tv18-idUSFWN1RJ00D", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Observes Alembic Pharma Failed To Review Any Unexplained Discrepancy On Inspection Of Co's Panelav Plant - CNBC TV18", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-06T08:27:00.000+03:00", "replies_count": 0, "uuid": "99e0fb3363fa43820c576b971719692fffd6862c"}, "author": "", "url": "https://www.reuters.com/article/brief-us-fda-observes-alembic-pharma-fai/brief-u-s-fda-observes-alembic-pharma-failed-to-review-any-unexplained-discrepancy-on-inspection-of-cos-panelav-plant-cnbc-tv18-idUSFWN1RJ00D", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Observes Alembic Pharma Failed To Review Any Unexplained Discrepancy On Inspection Of Co's Panelav Plant - CNBC TV18", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda observes alembic pharma", "sentiment": "negative"}, {"name": "cnbc", "sentiment": "negative"}, {"name": "fda observes alembic pharma failed to review any unexplained discrepancy on inspection of co", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "usfda observes alembic pharma", "sentiment": "none"}, {"name": "inspection of co", "sentiment": "none"}, {"name": "panelav plant - cnbc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 6, 2018 / 5:29 AM / Updated 12 minutes ago BRIEF-U.S. FDA Observes Alembic Pharma Failed To Review Any Unexplained Discrepancy On Inspection Of Co's Panelav Plant - CNBC TV18 Reuters Staff 1 Min Read \nApril 6 (Reuters) - \n* USFDA OBSERVES ALEMBIC PHARMA FAILED TO REVIEW ANY UNEXPLAINED DISCREPANCY AFTER INSPECTION OF CO’S PANELAV PLANT ON MARCH 12-20 -CNBC TV18 \n* USFDA OBSERVES ALEMBIC PHARMA EMPLOYEES NOT GIVEN TRAINING IN OPS THEY PERFORM AFTER INSPECTION OF CO’S PANELAV PLANT ON MARCH 12-20 -CNBC TV18 \n* USFDA OBSERVES ALEMBIC PHARMA HAS NO WRITTEN PROCEDURES FOR PRODUCTION & PROCESS CONTROLS-CNBC TV18 Source text: bit.ly/2uPxn19 Further company coverage:", "external_links": [], "published": "2018-04-06T08:27:00.000+03:00", "crawled": "2018-04-06T08:42:31.006+03:00", "highlightTitle": ""}